Dr. Nina Rawal founded Emerging Health Ventures in 2019.

Previously, she headed the life science investment team at Industrifonden, a 500 million EUR venture capital fund. Previous experience also includes the role of Vice President, Strategy and Ventures at Gambro AB, and management consulting at Boston Consulting Group in Stockholm and New York. She serves on the boards of MedCap AB (publ) and Stockholms Sjukhem, a non-profit hospital and health care organization. She holds a PhD in Molecular Neurobiology, and a MSc in Biomedicine, both from the Karolinska Institute, including research work done at Columbia University in New York and at Hôpital la Salpêtrière in Paris.
Recognition for her work includes the selection as a Young Global Leader by the World Economic Forum and a '40 under 40 - European Young Leader' by Friends of Europe/Europanova.